CN107496950B - 一种紫外线照射灭活蛋白溶液中病毒的方法 - Google Patents
一种紫外线照射灭活蛋白溶液中病毒的方法 Download PDFInfo
- Publication number
- CN107496950B CN107496950B CN201710713739.0A CN201710713739A CN107496950B CN 107496950 B CN107496950 B CN 107496950B CN 201710713739 A CN201710713739 A CN 201710713739A CN 107496950 B CN107496950 B CN 107496950B
- Authority
- CN
- China
- Prior art keywords
- protein solution
- ultraviolet
- ultraviolet lamp
- protein
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012460 protein solution Substances 0.000 title claims abstract description 186
- 241000700605 Viruses Species 0.000 title claims abstract description 110
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000000415 inactivating effect Effects 0.000 title claims abstract description 38
- 230000002779 inactivation Effects 0.000 claims abstract description 80
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 239000003223 protective agent Substances 0.000 claims description 27
- 230000002572 peristaltic effect Effects 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 12
- 230000001678 irradiating effect Effects 0.000 claims description 11
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 8
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 6
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 235000019192 riboflavin Nutrition 0.000 claims description 6
- 239000002151 riboflavin Substances 0.000 claims description 6
- 235000005493 rutin Nutrition 0.000 claims description 6
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 6
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 6
- 229960004555 rutoside Drugs 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 5
- 241001122767 Theaceae Species 0.000 claims description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 5
- 235000013824 polyphenols Nutrition 0.000 claims description 5
- -1 polytetrafluoroethylene Polymers 0.000 claims description 5
- 235000021283 resveratrol Nutrition 0.000 claims description 5
- 229940016667 resveratrol Drugs 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 claims description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 25
- 241000894006 Bacteria Species 0.000 abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 49
- 108010049003 Fibrinogen Proteins 0.000 description 46
- 102000008946 Fibrinogen Human genes 0.000 description 46
- 229940012952 fibrinogen Drugs 0.000 description 46
- 210000004027 cell Anatomy 0.000 description 41
- 241000702619 Porcine parvovirus Species 0.000 description 26
- 241000710960 Sindbis virus Species 0.000 description 22
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 22
- 241000711975 Vesicular stomatitis virus Species 0.000 description 22
- 210000003501 vero cell Anatomy 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 12
- 238000003756 stirring Methods 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- 239000012091 fetal bovine serum Substances 0.000 description 9
- 231100000915 pathological change Toxicity 0.000 description 9
- 230000036285 pathological change Effects 0.000 description 9
- 238000005086 pumping Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 238000005070 sampling Methods 0.000 description 8
- 230000001988 toxicity Effects 0.000 description 8
- 231100000419 toxicity Toxicity 0.000 description 8
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 8
- 238000012795 verification Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229940113082 thymine Drugs 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000002381 testicular Effects 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0047—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710713739.0A CN107496950B (zh) | 2017-08-18 | 2017-08-18 | 一种紫外线照射灭活蛋白溶液中病毒的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710713739.0A CN107496950B (zh) | 2017-08-18 | 2017-08-18 | 一种紫外线照射灭活蛋白溶液中病毒的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107496950A CN107496950A (zh) | 2017-12-22 |
CN107496950B true CN107496950B (zh) | 2021-02-02 |
Family
ID=60692209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710713739.0A Active CN107496950B (zh) | 2017-08-18 | 2017-08-18 | 一种紫外线照射灭活蛋白溶液中病毒的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107496950B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108524969A (zh) * | 2018-07-02 | 2018-09-14 | 苏州良辰生物医药科技有限公司 | 一种病毒灭活装置 |
CN110812505B (zh) * | 2019-08-20 | 2020-07-10 | 中科世生(北京)医药科技有限公司 | 一种血浆病毒灭活方法 |
CN110872345B (zh) * | 2019-08-20 | 2020-09-01 | 中科世生(北京)医药科技有限公司 | 一种高纯免疫球蛋白g的制备方法 |
CN110833627B (zh) * | 2019-11-25 | 2021-07-27 | 四川南格尔生物科技有限公司 | 一种紫外灭活仪 |
CN113332460A (zh) * | 2021-03-30 | 2021-09-03 | 张耀绵 | 一种含有维生素c溶液的紫外线c波处理方法 |
CN117599216B (zh) * | 2024-01-23 | 2024-03-26 | 苏州智核生物医药科技有限公司 | 一种促甲状腺激素蛋白生产过程病毒灭活及除菌装置 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1655828A (zh) * | 2000-11-13 | 2005-08-17 | 拜尔公司 | 使用紫外线辐射对流体中的微生物进行灭活的方法 |
CN203017432U (zh) * | 2013-01-21 | 2013-06-26 | 中国人民解放军总医院 | 一种流动式血浆病毒灭活设备 |
CN103705959A (zh) * | 2013-12-19 | 2014-04-09 | 陕西佰美基因股份有限公司 | 紫外辐照灭活血红蛋白及血红蛋白氧载体中病毒的方法 |
CN104248643A (zh) * | 2014-08-12 | 2014-12-31 | 中国人民解放军总医院 | 一种通用型病毒灭活血浆的制备装置及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403030B1 (en) * | 2000-07-31 | 2002-06-11 | Horton, Iii Isaac B. | Ultraviolet wastewater disinfection system and method |
WO2002092806A1 (en) * | 2001-05-15 | 2002-11-21 | V.I. Technologies, Inc. | Apparatus for the inactivation of pathogens in protein-containingfluids |
US7993580B2 (en) * | 2004-08-24 | 2011-08-09 | Baxter International Inc. | Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors |
MX2009013762A (es) * | 2007-06-15 | 2010-03-01 | Amgen Inc | Metodos para tratar medios de cultivo de celulas para uso en biorreactor. |
CN102318872B (zh) * | 2011-08-25 | 2014-07-30 | 佛山柯维光电股份有限公司 | 一种led紫外流体消毒装置 |
KR102091294B1 (ko) * | 2011-10-26 | 2020-04-16 | 암젠 인크 | Uv 광으로의 노출로 인한 단백질 변형 및 분해의 감소 또는 제거 방법 |
CN204671608U (zh) * | 2015-05-21 | 2015-09-30 | 胡芳 | 一种紫外发光二极管液体消毒器 |
-
2017
- 2017-08-18 CN CN201710713739.0A patent/CN107496950B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1655828A (zh) * | 2000-11-13 | 2005-08-17 | 拜尔公司 | 使用紫外线辐射对流体中的微生物进行灭活的方法 |
CN203017432U (zh) * | 2013-01-21 | 2013-06-26 | 中国人民解放军总医院 | 一种流动式血浆病毒灭活设备 |
CN103705959A (zh) * | 2013-12-19 | 2014-04-09 | 陕西佰美基因股份有限公司 | 紫外辐照灭活血红蛋白及血红蛋白氧载体中病毒的方法 |
CN104248643A (zh) * | 2014-08-12 | 2014-12-31 | 中国人民解放军总医院 | 一种通用型病毒灭活血浆的制备装置及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107496950A (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107496950B (zh) | 一种紫外线照射灭活蛋白溶液中病毒的方法 | |
US8986607B2 (en) | Method for the validatable inactivation of pathogens in a biological fluid by irradiation | |
JP4116429B2 (ja) | 紫外線放射を用いて流体中の微生物を不活性化する方法 | |
Bohrerova et al. | Comparative disinfection efficiency of pulsed and continuous-wave UV irradiation technologies | |
JP4939418B2 (ja) | 生物学的流体、フロー型反応器において微生物を不活性化するための方法およびバッチ式反応器中の微生物を効果的に不活性化するために総光線量を制御する方法 | |
JP2008510538A5 (zh) | ||
US10029926B2 (en) | System and method for inactivation of infectious pancreatic necrosis virus (IPNV) using medium pressure ultraviolet (UV) light | |
CN112640923A (zh) | 姜黄精油作为紫外杀菌增效剂的应用 | |
CN112450229B (zh) | 植物精油类紫外杀菌增效剂及其联合紫外进行杀菌的方法 | |
US20200138015A1 (en) | Apparatus and Methods for Irradiating Organ Perfusates | |
CN201777912U (zh) | 一种灯管交错排布的紫外线消毒装置 | |
Hamanaka et al. | Inactivation of pre-and post-germinated mold spores by infrared radiation heating and ultraviolet irradiation | |
Wang et al. | The inactivation effect of ultraviolet disinfection reactor on the high concentration of bacteriophage MS2 | |
CN117105324A (zh) | 一种基于双焦定位腔的紫外消毒装置 | |
CN116747326A (zh) | 一种紫外线照射灭活血浆中病毒的方法 | |
AU2007237275A1 (en) | Method of inactivating microorganisms in a fluid using ultraviolet radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou hi tech Industrial Development Zone, Guangdong Province Patentee after: Guangzhou Zhongwei Biotechnology Co.,Ltd. Patentee after: GUANGZHOU DIANFANG BIOTECH Co.,Ltd. Address before: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou hi tech Industrial Development Zone, Guangdong Province Patentee before: GUANGZHOU MUNICIPAL ZHONGWEI BIOTECHNOLOGY Co.,Ltd. Patentee before: GUANGZHOU DIANFANG BIOTECH Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210209 Address after: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU DIANFANG BIOTECH Co.,Ltd. Address before: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou hi tech Industrial Development Zone, Guangdong Province Patentee before: Guangzhou Zhongwei Biotechnology Co.,Ltd. Patentee before: GUANGZHOU DIANFANG BIOTECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee after: Guangzhou Huasong Biotechnology Co.,Ltd. Address before: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU DIANFANG BIOTECH Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220512 Address after: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU BAITESONG MEDICINE SCIENCE & TECHNOLOGY CO.,LTD. Address before: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee before: Guangzhou Huasong Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220627 Address after: 510000 No.1, Wanbao North Street, Panyu District, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU BAIYUSHAN BAIDI BIOTECHNOLOGY CO.,LTD. Address before: 510663 room e413, Zone E, Guangzhou International Business Incubator, No.3, Juquan Road, Science City, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU BAITESONG MEDICINE SCIENCE & TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |